Sciencedirect Downloaded
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
Oral lipid-based drug delivery systems – an overview
Fundamental aspects of solid dispersion technology for poorly soluble drugs
Smart polymers for the controlled delivery of drugs – a concise overview
Cancer stem cells: therapeutic implications and perspectives in cancer therapy
Glycolysis in the control of blood glucose homeostasis
Effects and mechanisms of berberine in diabetes treatment
Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
Enzyme-mediated hydrolytic activation of prodrugs
Nutraceuticals as potential therapeutic agents for colon cancer: a review
Brain tumor-targeted drug delivery strategies
Inhibition of tyrosinase activity and melanine pigmentation by 2-hydroxytyrosol
Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications
Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges
Nonionic surfactant vesicular systems for effective drug delivery—an overview
Mechanisms of acquired resistance to tyrosine kinase inhibitors
Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance
Current strategies for drug delivery to the inner ear
The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics

First Previous Next Last